Plasma C-Reactive protein and Endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension

Journal of Korean Medical Science

Volumn 25, Issue 10, 2010, Pages 1487-1491

  Kwon, Yong Soo ^a   Chi, Su Young ^a   Shin, Hong Joon ^a   Kim, Eun Young ^a   Yoon, Byeong Kab ^a   Ban, Hee Jung ^a   Oh, In Jae ^a   Kim, Kyu Sik ^a   Kim, Young Chul ^a   Lim, Sung Chul ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

C Reactive protein; Chronic obstructive pulmonary disease; Endothelin 1; Pulmonary hypertension

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIN 1;

AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PULMONARY HYPERTENSION;

AGED; BLOOD PRESSURE; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 78449299430     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.10.1487     Document Type: Article

References (29)

1. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Torax 2005; 60: 605-9.
2. Jung HS, Lee JH, Chun EM, Moon JW, Chang JH. Predictors of long-term mortality after hospitalization for acute exacerbation of COPD. Tuberc Respir Dis 2006; 60: 205-14.
3. Jyothula S, Safdar Z. Update on pulmonary hypertension complicating chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009; 4: 351-63.
4. Barberà JA, Riverola A, Roca J, Ramirez J, Wagner PD, Ros D, Wiggs BR, Rodriguez-Roisin R. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 423-9.
5. Santos S, Peinado VI, Ramírez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barberà JA. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 2002; 19: 632-8.
6. Joppa P, Petrasova D, Stancak B, Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006; 130: 326-33.
7. Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, Canuet M, Maitre B, Housset B, Brandt C, Le Corvoisier P, Weitzenblum E, Eddahibi S, Adnot S. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009; 136: 678-87.
8. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992; 4: 361-8.
9. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
10. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
11. Allen SW, Chatfield BA, Koppenhafer SA, Schafer MS, Wolfe RR, Abman SH. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 1993; 148: 519-22.
12. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: Marked elevations in patients with cardiogenic shock. Biochem Biophys Res Commun 1989; 161: 562-7.
13. Bacakoǧlu F, Atasever A, Ozhan MH, Gurgun C, Ozkilic H, Guzelant A. Plasma and bronchoalveolar lavage fluid levels of endothelin-1 in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Respiration 2003; 70: 594-9.
14. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 532-55.
15. Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104: 236-50.
16. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl S): 40S-7S.
17. Sekhon HS, Wright JL, Churg A. Cigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteries. Am J Physiol 1994; 267: L557-63.
18. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Torax 2006; 61: 849-53.
19. de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Córdoba-Lanús E, Muros de Fuentes M, Aguirre-Jaime A, Celli BR. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008; 133: 1336-43.
20. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328: 1732-9.
21. Cacoub P, Dorent R, Nataf P, Carayon A, Riquet M, Noe E, Piette JC, Godeau P, Gandjbakhch I. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997; 33: 196-200.
22. Fujii T, Otsuka T, Tanaka S, Kanazawa H, Hirata K, Kohno M, Kurihara N, Yoshikawa J. Plasma endothelin-1 level in chronic obstructive pulmonary disease: relationship with natriuretic peptide. Respiration 1999; 66: 212-9.
23. Mullol J, Baraniuk JN, Logun C, Benfield T, Picado C, Shelhamer JH. Endothelin-1 induces GM-CSF, IL-6 and IL-8 but not G-CSF release from a human bronchial epithelial cell line (BEAS-2B). Neuropeptides 1996; 30: 551-6.
24. Redington AE, Springall DR, Ghatei MA, Lau LC, Bloom SR, Holgate ST, Polak JM, Howarth PH. Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Respir Crit Care Med 1995; 151: 1034-9.
25. Chalmers GW, Tomson L, Macleod KJ, Dagg KD, McGinn BJ, McSharry C, Patel KR, Tomson NC. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects. Torax 1997; 52: 625-7.
26. Goldie RG, Knott PG, Carr MJ, Hay DW, Henry PJ. The endothelins in the pulmonary system. Pulm Pharmacol 1996; 9: 69-93.
27. Wang C, Liu J, Guo F, Ji Y, Liu N. Endothelin-1 induces the expression of C-reactive protein in rat vascular smooth muscle cells. Biochem Biophys Res Commun 2009; 389: 537-42.
28. Katayama T, Yano K, Nakashima H, Takagi C, Honda Y, Suzuki S, Iwasaki Y. Clinical significance of acute-phase endothelin-1 in acute myocardial infarction patients treated with direct coronary angioplasty. Circ J 2005; 69: 654-8.
29. Gemici G, Erdim R, Tokay S, Tezcan H, Fak AS, Oktay A. Interaction between C-reactive protein and endothelin-1 in coronary artery disease. Cardiology 2007; 107: 340-4.